Tech transfer partnership between universities creates company to transform care for millions of women

Published on July 30, 2024

Amber Therapeutics (Tx), a start-up involving the University of Oxford, has just completed a $100 million Series A funding round from healthcare and technology investors in the US and UK to develop treatment for mixed urinary incontinence.
Continue reading on website
Other news

New shingles vaccine could reduce risk of dementia

July 25, 2024
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine. It is also more protective than vaccines against other infections.

New study highlights scale and impact of Long COVID

July 30, 2024
A new state of the art review, published in The Lancet, highlights the scale and impact of Long COVID. It explains biological mechanisms behind the condition and suggests priority areas for future research.